CD4 and COVID-19: A role for these pre-existing T-cells in immune protection is supported by studies showing the presence of highly responsive cross-reactive cells in seronegative health care workers with abortive infections (42), and a positive correlation with increased CoV2-specific CD4+ T-cell and antibody responses to COVID-19 mRNA vaccines (41, 43).